Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Improving Sarcopenia During Chemotherapy
Authors not listed
National Taiwan University Hospital · 2025
Abstract
This study aims to investigate whether a high-protein nutritional supplement (ETHANWELL BALANCED) can help improve muscle strength and reduce fatigue in cancer patients who are at risk of sarcopenia (age- or disease-related muscle loss) during chemotherapy. Sarcopenia is common in older adults and cancer patients and can lead to weakness, poor treatment tolerance, and reduced quality of life.
Participants aged 40 and older, receiving chemotherapy, and showing early signs of sarcopenia will be randomly assigned to two groups. The experimental group will receive nutritional education and take a high-protein nutritional drink three times per day for 8 weeks. Both groups will continue their usual medical care and perform simple resistance exercises at home.
Researchers will measure changes in grip strength, fatigue, quality of life, and nutritional status over a 12-week period. This study will help determine whether early nutrition intervention can improve treatment outcomes and quality of life for cancer patients with sarcopenia.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
Anonymous. (2025). Improving Sarcopenia During Chemotherapy. <em>National Taiwan University Hospital</em>. https://clinicaltrials.gov/study/NCT07114588
Vancouver
Anonymous. Improving Sarcopenia During Chemotherapy. National Taiwan University Hospital. 2025.
BibTeX
@misc{anon2025Improv,
title = {Improving Sarcopenia During Chemotherapy},
author = {Anonymous},
journal = {National Taiwan University Hospital},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Salamanca 2026
Open access · US-GOV
Intrahospital Exercise Program in Hemodialysis Patients: Impact on Sarcopenia Markers, Sleep Quality, and Quality of Life.
Gali Perel 2026
Open access · US-GOV
CuliCan Study A Multimodal Approach to Mitigate Muscle Mass Loss in Advanced Cancer Patients: Personalized Culinary Advice Addressing Mild to Moderate Muscle Mass Loss
London North West Healthcare NHS Trust 2022
Open access · US-GOV
Use of Perioperative Testosterone Replacement Therapy (TRT) in Sarcopenic Male Colorectal Cancer Patients - A Single Arm Open Label Feasibility Study
China Medical University Hospital 2025
Open access · US-GOV
Evaluation of the JUICE HA® as an Anti-sarcopenia
Institute of Oncology Ljubljana 2023
Open access · US-GOV
Evaluation of the Proportion of Patients With Gastrointestinal Cancer Who Have Symptoms of Sarcopenia
King Edward Medical University 2026
Open access · US-GOV